Resmed Inc
NYSE:RMD
Resmed Inc
Net Income (Common)
Resmed Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Resmed Inc
NYSE:RMD
|
Net Income (Common)
$958.4m
|
CAGR 3-Years
28%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Resmed Inc's Net Income (Common)?
Net Income (Common)
958.4m
USD
Based on the financial report for Mar 31, 2024, Resmed Inc's Net Income (Common) amounts to 958.4m USD.
What is Resmed Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
11%
Over the last year, the Net Income (Common) growth was 11%. The average annual Net Income (Common) growth rates for Resmed Inc have been 28% over the past three years , 17% over the past five years , and 11% over the past ten years .